Improved prognosis following renin-angiotensin-aldosterone system blockade in patients undergoing concomitant aortic and mitral valve replacement

Int J Cardiol. 2014 Dec 15;177(2):680-2. doi: 10.1016/j.ijcard.2014.09.163. Epub 2014 Oct 5.
No abstract available

Keywords: ACEI; ARB; DVR; Prognosis; Renin–angiotensin–aldosterone system.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aldosterone / metabolism
  • Angiotensin Receptor Antagonists / pharmacology
  • Angiotensin Receptor Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Aortic Valve
  • Bicuspid Aortic Valve Disease
  • Female
  • Follow-Up Studies
  • Heart Defects, Congenital / diagnosis*
  • Heart Defects, Congenital / mortality
  • Heart Defects, Congenital / therapy
  • Heart Valve Diseases / diagnosis*
  • Heart Valve Diseases / mortality
  • Heart Valve Diseases / therapy
  • Heart Valve Prosthesis Implantation / mortality
  • Heart Valve Prosthesis Implantation / trends*
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve Insufficiency / diagnosis*
  • Mitral Valve Insufficiency / mortality
  • Mitral Valve Insufficiency / therapy
  • Mitral Valve Stenosis / diagnosis*
  • Mitral Valve Stenosis / mortality
  • Mitral Valve Stenosis / therapy
  • Prognosis
  • Renin-Angiotensin System / drug effects
  • Renin-Angiotensin System / physiology
  • Survival Rate / trends

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Aldosterone